Metabolic monitoring and interventions for reducing metabolic syndrome in patients treated with atypical antipsychotics: a review of the clinical evidence
Canadian Agency for Drugs and Technologies in Health
Record ID 32011001505
English
Authors' recommendations:
Limited evidence is available on the interventions which treat metabolic risk factors. Low quality studies and inconsistent reporting of clinical outcomes make it difficult to draw definitive conclusions on the optimal intervention to prevent or manage metabolic syndrome.
Details
Project Status:
Completed
Year Published:
2011
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Monitoring, Physiologic
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.